Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted Total Non-Current Liabilities of $9.5 billion for Q2 2026, up 1.25% on a QoQ basis from $9.4 billion in Q1 2026, and up 0.79% year-over-year from $9.5 billion in Q2 2025.
Analysis
Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported Total Non-Current Liabilities for 18 years, with the latest figure at $9.5 billion in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 0.79% year-over-year to $9.5 billion in Q2 2026; TTM through Jun 2026 was $9.5 billion, a 0.79% increase from a year earlier, with the FY2025 full-year figure at $9.8 billion, up 19.83% from the prior year.
- Total Non-Current Liabilities was $9.5 billion for Q2 2026 at Zimmer Biomet Holdings, up from $9.4 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $9.9 billion in Q3 2025, with the low at $7.6 billion in Q2 2024.
- Average Total Non-Current Liabilities over 5 years is $8.7 billion, with a median of $8.5 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities slipped 20.83% in 2022, then gained 24.94% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $8.4 billion in 2022, then fell by 3.85% to $8.1 billion in 2023, then gained by 0.77% to $8.1 billion in 2024, then increased by 19.83% to $9.8 billion in 2025, then decreased by 2.39% to $9.5 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $9.5 billion (Q2 2026), $9.4 billion (Q1 2026), and $9.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.53 Bn |
| Mar 31, 2026 | 9.41 Bn |
| Dec 31, 2025 | 9.76 Bn |
| Sep 30, 2025 | 9.92 Bn |
| Jun 30, 2025 | 9.45 Bn |
| Mar 31, 2025 | 8.87 Bn |
| Dec 31, 2024 | 8.15 Bn |
| Sep 30, 2024 | 8.31 Bn |
| Jun 30, 2024 | 7.57 Bn |
| Mar 31, 2024 | 8.27 Bn |
| Dec 31, 2023 | 8.08 Bn |
| Sep 30, 2023 | 8.07 Bn |
| Jun 30, 2023 | 8.27 Bn |
| Mar 31, 2023 | 8.45 Bn |
| Dec 31, 2022 | 8.41 Bn |
| Sep 30, 2022 | 8.47 Bn |
| Jun 30, 2022 | 8.74 Bn |
| Mar 31, 2022 | 9.00 Bn |
| Dec 31, 2021 | 10.21 Bn |
| Sep 30, 2021 | 10.69 Bn |